Authored: 20/03/2025

Rybelsus is a once-daily oral tablet containing Semaglutide that helps suppress appetite and supports weight loss of around 10%.
Mounjaro is currently the latest generation GLP1 treatment available in the UK. This can help patients achieve 15-22.5% body weight loss.
Rybelsus is an effective weight-loss tablet designed to help you feel less hungry. It is taken orally once daily.
Rybelsus tablets are not licensed for weight loss in the UK. This is a prescription weight-loss medication, prescribed for type 2 diabetes.
They contains the active ingredient semaglutide, which is the same ingredient as the injectable weight loss medication "Wegovy".
Dose | One tablet daily, following the dose-escalation schedule |
---|---|
Type of medicine | Appetite-suppressant - GLP-1 receptor agonist |
Mechanism | Suppresses appetite, enhances satiety, reduces calorie intake |
Active Ingredient | Semaglutide |
Side Effects | Can include nausea, diarrhoea, constipation, abdominal pain, vomiting |
Rybelsus is a prescription weight-loss tablet containing semaglutide. It helps weight loss by reducing appetite and calorie intake. It is suitable for adults with a body mass index (BMI) over 30 or a BMI over 27 with weight-related conditions such as high blood pressure or type 2 diabetes.
Rybelsus | Wegovy | |
Dose | One tablet DAILY | One injection WEEKLY |
Administration | Oral Tablet | Subcutaneous Injection |
Price per month | From £85 | From £139 |
Effectiveness | ~10% body weight loss | ~15% body weight loss |
Rybelsus prices start from £85 per month, depending on the strength. Monthly packs vary in price based on dosage:
Rybelsus tablets are taken once daily. The tablet should be swallowed whole with a sip of water on an empty stomach. Wait at least 30 minutes before eating, drinking, or taking other medication. The recommended dose is gradually increased to reduce side effects:
Clinical trials have shown Rybelsus significantly reduces body weight. In trials, patients achieved around 10% weight loss when combined with diet and exercise, compared to placebo.
However, at Simple Online Pharmacy, we do no prescribe Rybselsus as part of our weight loss service. Instead, we prescribe the licensed versions of this treatment, Wegovy and Mounjaro.
Rybelsus isn't suitable if you've had allergic reactions to semaglutide or its ingredients. It can cause digestive symptoms, increasing dehydration risk. Drink plenty of fluids.
People with diabetes shouldn't use Rybelsus as an insulin substitute. It may increase the risk of low blood sugar if combined with other diabetes medications.
Rybelsus should not be used during pregnancy or breastfeeding and should be discontinued at least 2 months before planning pregnancy.
Common side effects include nausea, vomiting, diarrhoea, constipation, abdominal pain, and fatigue. These usually improve over time. If side effects persist or are severe, seek medical advice.
Other options include injectable treatments like Mounjaro, Saxenda or Wegovy. Oral options include Orlistat.
Visit our weight loss clinic for more information.
All of our medication and condition content is written by UK qualified pharmacists and doctors.
Authored: 20/03/2025
Reviewed: 22/04/2025
Saxenda | Xenical | Orlistat | Mysimba | |
Ingredient | Liraglutide | Orlistat 120mg | Orlistat 120mg | Naltrexone/Bupropion |
Mechanism | Regulates appetite | Reduces fat absorption | Reduces fat absorption | Regulates appetite |
Dose | Injected once daily | One three times daily with meals | One three times daily with meals | Gradually increased to 4 tablets daily |